NeoGenomics Inc (NEO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6602
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry; and molecular genetics including sanger sequencing and fragment analysis. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services for detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations, and others. NeoGenomics provides biopharma services which supports drug development programs from early biomarker discovery to clinical trials. The company serves oncologists, pathologists, pharmaceutical companies, academic centers, and others. NeoGenomics is headquartered in Fort Myers, Florida, the US.

NeoGenomics Inc (NEO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeoGenomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeoGenomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
NeoGenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NeoGenomics Inc, Medical Equipment, Deal Details 11
Partnerships 11
Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 11
Health Discovery Enters Into Licensing Agreement With NeoGenomics 12
NeoGenomics and Definiens Enter into Agreement 13
Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services 14
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit 15
Equity Offering 16
NeoGenomics Prices Public Offering of Shares for USD125 Million 16
NeoGenomics Raises USD37 Million in Public Offering of Shares 18
NeoGenomics Completes Public Offering Of Shares For US$10 Million 20
Acquisition 21
NeoGenomics Acquires Clarient from GE Healthcare 21
NeoGenomics Inc – Key Competitors 23
NeoGenomics Inc – Key Employees 24
NeoGenomics Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
Jun 01, 2018: PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions 27
Nov 09, 2017: NeoGenomics Europe Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials 28
Financial Announcements 29
Jul 24, 2018: NeoGenomics reports record revenue of $67.7 million with 14% increase in clinical volume growth and 95% increase in pharma services backlog 29
May 01, 2018: NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018 31
Feb 21, 2018: NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017 33
Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017 34
Apr 26, 2017: NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017 35
Feb 22, 2017: NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016 37
Corporate Communications 39
Mar 20, 2018: NeoGenomics Announces Executive Appointments 39
Apr 20, 2017: NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development 40
Product News 41
Sep 24, 2018: NeoGenomics announces participation in NCI-MATCH clinical trial 41
Jun 02, 2017: NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
NeoGenomics Inc, Medical Equipment, Key Facts, 2017 2
NeoGenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeoGenomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeoGenomics Inc, Deals By Market, 2012 to YTD 2018 9
NeoGenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 11
Health Discovery Enters Into Licensing Agreement With NeoGenomics 12
NeoGenomics and Definiens Enter into Agreement 13
Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services 14
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit 15
NeoGenomics Prices Public Offering of Shares for USD125 Million 16
NeoGenomics Raises USD37 Million in Public Offering of Shares 18
NeoGenomics Completes Public Offering Of Shares For US$10 Million 20
NeoGenomics Acquires Clarient from GE Healthcare 21
NeoGenomics Inc, Key Competitors 23
NeoGenomics Inc, Key Employees 24
NeoGenomics Inc, Other Locations 25
NeoGenomics Inc, Subsidiaries 26

List of Figures
NeoGenomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NeoGenomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NeoGenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeoGenomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
NeoGenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeoGenomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[NeoGenomics Inc (NEO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Wartsila Corp (WRT1V):企業の財務・戦略的SWOT分析
    Wartsila Corp (WRT1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fibra Uno Administracion, S. A. De C. V.:企業の戦略・SWOT・財務分析
    Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report Summary Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • FP Corporation:企業の戦略・SWOT・財務情報
    FP Corporation - Strategy, SWOT and Corporate Finance Report Summary FP Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EVA Airways Corporation:企業の戦略・SWOT・財務情報
    EVA Airways Corporation - Strategy, SWOT and Corporate Finance Report Summary EVA Airways Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Charter Hall Group:企業のM&A・事業提携・投資動向
    Charter Hall Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charter Hall Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Aptinyx Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aptinyx Inc (Aptinyx), formerly Enarex, Inc., is a biopharmaceutical company which focuses on the discovery and development of novel therapies for the treatment of brain and nervous system disorders. The company has a robust chemistry library with small molecule compounds which are designed …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Energias de Portugal SA (EDP):電力:M&Aディール及び事業提携情報
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Caspian Energy Inc. (CKZ.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Energy Inc (CEI) is an independent upstream oil and gas company. It carries out the exploration, development, and production of oil and gas. and the company, along with its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license to explore and deve …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Choppies Enterprises Ltd:企業の戦略的SWOT分析
    Choppies Enterprises Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務情報
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Qioptiq Group:企業の戦略的SWOT分析
    Qioptiq Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Thoresen Thai Agencies Public Company Limited:企業の戦略・SWOT・財務情報
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Northwestern University:企業のM&A・事業提携・投資動向
    Northwestern University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northwestern University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆